Search clinical trials for: Idelalisib
Total 71 results
-
Dana-Farber Cancer InstituteGilead SciencesTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Institut Paoli-CalmettesCHU de ReimsUnknownAutoimmune Cytopenia Associated With Chronic Lymphocytic LeukemiaFrance
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Gilead SciencesTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | B Cell Chronic Lymphocytic Leukemia | B Cells-Tumors | Large B-Cell Diffuse Lymphoma of Bone (Diagnosis)United States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoERIC GroupCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene Corporation; Biologics...CompletedRelapsed/Refractory Mantle Cell LymphomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene CorporationCompletedRecurrent Follicular LymphomaUnited States
-
PETHEMA FoundationTerminatedAcute Lymphoblastic LeukemiaSpain
-
Nordic Lymphoma GroupCompletedDiffuse Large B Cell LymphomaDenmark, Sweden
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States, France, United Kingdom, Germany, Italy
-
Gilead SciencesCompletedChronic Lymphocytic Leukemia (CLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Lymphoma, Non-Hodgkin (NHL)United States
-
University of Maryland, BaltimoreGilead Sciences; University of Miami Sylvester Comprehensive Cancer CenterActive, not recruitingFollicular Lymphoma | B-cell Lymphoma | Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Non Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Transformed Lymphoma | Indolent LymphomaUnited States
-
Gilead SciencesTerminatedLymphoid MalignanciesNetherlands
-
John Mark SloanGilead SciencesTerminated
-
Novartis PharmaceuticalsCompletedFollicular Lymphoma, Mantle Cell LymphomaAustria, France, United States, Germany
-
Gilead SciencesCompletedFollicular Non-Hodgkin's Lymphoma RefractorySpain, France, Ireland, Italy, Greece, Germany, United Kingdom, Sweden, Belgium, Portugal
-
Dana-Farber Cancer InstituteGlaxoSmithKline; Gilead SciencesActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Gilead SciencesWithdrawn
-
Gilead SciencesCompleted
-
Gilead SciencesTerminatedLymphoma, Non-Hodgkin | Chronic Lymphocytic LeukemiaUnited States
-
Gilead SciencesCompletedHodgkin LymphomaUnited States
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)Japan
-
Fondazione Italiana Linfomi - ETSTerminatedFollicular LymphomaItaly
-
French Innovative Leukemia OrganisationCompletedWaldenstrom MacroglobulinemiaFrance
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States, Hungary, Belgium, United Kingdom, France, Australia, Turkey, Croatia, Italy, Poland, Canada, Greece, Czechia, Ireland, Russian Federation, Spain, Portugal, Romania
-
Gilead SciencesTerminatedChronic Lymphocytic LeukemiaUnited States, France, United Kingdom, Germany, Italy
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Small Lymphocytic LymphomaUnited States, United Kingdom, Italy, Germany, Poland, France
-
Dana-Farber Cancer InstituteAcetylon Pharmaceuticals IncorporatedActive, not recruitingRecurrent Chronic Lymphoid LeukemiaUnited States
-
Gilead SciencesTerminated
-
Gilead SciencesTerminatedChronic Lymphocytic LeukemiaUnited States, Spain, Belgium, Canada, United Kingdom, Australia, Denmark, Poland, Ireland, France, Sweden
-
Gilead SciencesTerminatedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
ADC Therapeutics S.A.TerminatedRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited States, Belgium, Hungary, Israel, Spain, Switzerland, Poland, France, United Kingdom, Italy
-
Gilead SciencesTerminatedFollicular LymphomaSpain, Italy, France, Poland, Israel, United Kingdom, Czechia, Romania, Australia, Canada
-
Gilead SciencesBoehringer IngelheimTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
Asha NayakMerck Sharp & Dohme LLC; Gilead SciencesTerminatedRecurrence | Non Small Cell Lung Cancer | MetastasisUnited States
-
Merck Sharp & Dohme LLCCompletedMelanoma | Glioblastoma Multiforme | Recurrence of Solid Tumor
-
Gilead SciencesCompletedChronic Lymphocytic LeukaemiaUnited Kingdom, Ireland
-
Gilead SciencesGerman CLL Study GroupCompleted
-
Gilead SciencesTerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
Gilead SciencesActive, not recruitingB-cell MalignanciesUnited States, United Kingdom, France
-
Gilead SciencesTerminatedChronic Lymphocytic LeukemiaUnited States, France, Spain, Poland, United Kingdom, Australia, Belgium, Canada
-
German CLL Study GroupGilead Sciences; Hoffmann-La RocheCompletedChronic Lymphocytic LeucemiaGermany
-
MorphoSys AGCompletedLeukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, United Kingdom, Austria, Germany, Italy, Poland
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic LeukemiaUnited States
-
Gilead SciencesTerminatedB-cell Chronic Lymphocytic Leukemia (CLL) With 17p DeletionUnited States, Spain, Denmark, Belgium, Australia, Poland, Romania, Czechia, Italy, France, Hungary, Austria, Portugal, United Kingdom
-
Gilead SciencesApproved for marketingChronic Lymphocytic Leukemia (CLL)United States, Italy, United Kingdom, Ireland
-
Gilead SciencesTerminatedFollicular Lymphoma | Small Lymphocytic LymphomaUnited States
-
Aptevo TherapeuticsTerminatedChronic Lymphocytic Leukemia | Peripheral T-cell LymphomaUnited States
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Hungary, United Kingdom, Australia, Singapore, Japan, Taiwan, Israel, Italy, Spain, Czechia, Russian Federation, France, Poland, Romania, Germany, Portugal, Sweden
-
Gilead SciencesTerminatedPreviously Untreated Pancreatic Ductal Adenocarcinoma | Relapsed/Refractory Pancreatic Ductal AdenocarcinomaUnited States